|
IL76360A0
(en)
|
1984-09-26 |
1986-01-31 |
Takeda Chemical Industries Ltd |
Mutual separation of proteins
|
|
JP2675294B2
(ja)
*
|
1984-10-15 |
1997-11-12 |
カイロン コーポレイション |
ヒト腫瘍壊死因子
|
|
EP0200748B1
(en)
*
|
1984-10-15 |
1991-02-06 |
Cetus Corporation |
Human tumor necrosis factor
|
|
US4572798A
(en)
*
|
1984-12-06 |
1986-02-25 |
Cetus Corporation |
Method for promoting disulfide bond formation in recombinant proteins
|
|
JP2583753B2
(ja)
*
|
1984-12-21 |
1997-02-19 |
大塚製薬株式会社 |
抗腫瘍活性物質およびその製造法
|
|
JP2721854B2
(ja)
*
|
1984-12-21 |
1998-03-04 |
大塚製薬株式会社 |
抗腫瘍活性物質
|
|
DE3613390C2
(de)
*
|
1985-04-22 |
2001-10-11 |
Genentech Inc |
Einkettige Human-Gewebeplasminogen-Aktivator (t-PA)-Mutanten, kodierende DNA, Expressionsvektor, Mikroorganismus, Zellkultur und pharmazeutische Zusammensetzung
|
|
US4818698A
(en)
*
|
1985-08-23 |
1989-04-04 |
Toyo Jozo Co., Ltd. |
Polypeptides and preparation process thereof
|
|
NZ226543A
(en)
*
|
1987-10-22 |
1992-02-25 |
Merck & Co Inc |
Recombinant mutant acidic fibroblast growth factor
|
|
ATE133993T1
(de)
*
|
1989-02-17 |
1996-02-15 |
Merck & Co Inc |
Protein-antikrebsmittel
|
|
IL93723A
(en)
*
|
1989-03-22 |
1997-02-18 |
Merck & Co Inc |
Cystein modified truncated pseudomonas exotoxin A
|
|
US6207798B1
(en)
|
1989-08-03 |
2001-03-27 |
Merck & Co., Inc. |
Modified PE40 toxin fusion proteins
|
|
JPH0751621A
(ja)
*
|
1993-08-12 |
1995-02-28 |
Kansei Kogyo Kk |
静電吸着による管内面更生工法
|
|
UY27373A1
(es)
*
|
2001-07-09 |
2003-02-28 |
Schering Ag |
Formulaciones de interferón beta-humano
|
|
AU2004264855A1
(en)
*
|
2003-07-11 |
2005-02-24 |
Schering Aktiengesellschaft |
Improved recombinant human interferon-beta-1b polypeptides
|
|
US20240270807A1
(en)
*
|
2020-04-29 |
2024-08-15 |
Genopharm Inc. |
Recombinant protein having fused interferon-beta mutein and antibody, and pharmaceutical composition comprising same
|